Cleared Traditional

K973099 - PROSTATE SPECIFIC ANTIGEN CONTROL

K973099 is an FDA 510(k) clearance for PROSTATE SPECIFIC ANTIGEN CONTROL, manufactured by Dade Chemistry Systems, Inc.. The device is a Class 1 Immunology device with product code JJX cleared through the Traditional 510(k) pathway after a 41-day FDA review.

K973099 · Dade Chemistry Systems, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1997
Decision
41d
Days
Class 1
Risk

K973099 is an FDA 510(k) clearance for the PROSTATE SPECIFIC ANTIGEN CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Dade Chemistry Systems, Inc. (Newark, US). The FDA issued a Cleared decision on September 29, 1997 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade Chemistry Systems, Inc. devices

FDA 510(k) Submission Details - K973099

510(k) Number K973099 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 1997
Decision Date September 29, 1997
Days to Decision 41 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 105d · This submission: 41d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 421
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K973099.
SERUM HCG CONTROL SET (NEGATIVE, LOW POSITIVE AND HIGH POSITIVE)
K974108 · Quidel Corp. · Nov 1997
OPUS HLH CONTROLS
K973832 · Behring Diagnostics, Inc. · Oct 1997
MYOGLOBIN CONTROL SET
K973358 · Boehringer Mannheim Corp. · Oct 1997
WAKO NEFA LINEARITY SET
K973072 · Wako Chemicals USA, Inc. · Sep 1997
ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P
K972721 · Roche Diagnostic Systems, Inc. · Aug 1997
CARDIAC STATUS CONTROLS/TROPONIN I
K972687 · Spectral Diagnostics, Inc. · Jul 1997